Get started
Author

Beatrix Bálint

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
2015 · Nick Thatcher, Fred R Hirsch, et al. · The Lancet Oncology · 484
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non–Small-Cell Lung Cancer
2010 · Giorgio Scagliotti, Silvia Novello, et al. · Journal of Clinical Oncology · 447
PDF
Increased Leukotrienes in Exhaled Breath Condensate in Childhood Asthma
2002 · Zsuzsanna Csoma, Sergei A. Kharitonov, et al. · American Journal of Respiratory and Critical Care Medicine · 200
Increased nitric oxide metabolites in exhaled breath condensate after exposure to tobacco smoke
2001 · B Balint, L E Donnelly, et al. · Thorax · 152
PDF
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
2015 · Luis Paz-Ares, Jörg Mezger, et al. · The Lancet Oncology · 135
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis
2001 · B. Balint, S.A. Kharitonov, et al. · European Respiratory Journal · 118
PDF
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD
2015 · A.M. Kirsten, K. Förster, et al. · Pulmonary Pharmacology & Therapeutics · 92
A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
2013 · Luis Paz-Ares, Beatrix Bálint, et al. · Journal of Thoracic Oncology · 74
PDF
Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety
2012 · Anna Bodzenta-Lukaszyk, Roland Buhl, et al. · Journal of Asthma · 52
Nitric Oxide Metabolites Are Not Reduced in Exhaled Breath Condensate of Patients With Primary Ciliary Dyskinesia*
2003 · Zsuzsanna Csoma, Andrew Bush, et al. · CHEST Journal · 51
A randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin (GC) chemotherapy plus necitumumab (IMC-11F8/LY3012211) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC).
2014 · Nick Thatcher, Fred R. Hirsch, et al. · Journal of Clinical Oncology · 41
Weather elements, chemical air pollutants and airborne pollen influencing asthma emergency room visits in Szeged, Hungary: performance of two objective weather classifications
2014 · László Makra, János Puskás, et al. · International Journal of Biometeorology · 31
PDF
Multivariate analysis of respiratory problems and their connection with meteorological parameters and the main biological and chemical air pollutants
2011 · István Matyasovszky, László Makra, et al. · Atmospheric Environment · 28
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)
2021 · Dmytro Trukhin, Elena Poddubskaya, et al. · BioDrugs · 27
PDF
Association of allergic asthma emergency room visits with the main biological and chemical air pollutants
2012 · László Makra, István Matyasovszky, et al. · The Science of The Total Environment · 26
Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer
2017 · Tudor Ciuleanu, Mark A. Socinski, et al. · Clinical Lung Cancer · 24
Influences of meteorological parameters and biological and chemical air pollutants on the incidence of asthma and rhinitis
2008 · L Makra, S Tombácz, et al. · Climate Research · 20
PDF
Association of allergic rhinitis or asthma with pollen and chemical pollutants in Szeged, Hungary, 1999–2007
2013 · László Makra, István Matyasovszky, et al. · International Journal of Biometeorology · 14
PDF
C6-01: Correlations of biomarker expression and clinical outcome in a large phase III trial of pemetrexed plus cisplatin or gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
2007 · Giorgio Scagliotti, Christopher Kaiser, et al. · Journal of Thoracic Oncology · 13
PDF
Carboplatin-paclitaxel/nab-paclitaxel with or without pembrolizumab in first-line metastatic squamous NSCLC: Results from the KEYNOTE-407 east Asia subgroup
2018 · T. Kato, S. Lee, et al. · Annals of Oncology · 4
PDF
Squire: a Randomized, Multicenter, Open-Label, Phase III Study of Gemcitabine-Cisplatin (Gc) Chemotherapy Plus Necitumumab (Imc-11F8/Ly3012211) Vs Gc Alone in the First-Line Treatment of Patients (Pts) with Stage Iv Squamous Non-Small Cell Lung Cancer (Sq-Nsclc): Update on Key Subgroups
2014 · M.A. Socinski, L. Paz-Ares, et al. · Annals of Oncology · 3
Adjuvant docetaxel plus cisplatin in stage I/II non-small cell lung cancer (NSCLC): Preliminary results of a randomized phase II pilot trial of the Central European Cooperative Oncology Group (CECOG)
2004 · S. Tomek, A. End, et al. · Journal of Clinical Oncology · 3
Subgroup analyses by performance status (PS) in the phase III SQUIRE study: First-line necitumumab (N) plus gemcitabine-cisplatin (GC) vs. GC in squamous non-small cell lung cancer (NSCLC).
2015 · Mark A. Socinski, Alexander Luft, et al. · Journal of Clinical Oncology · 2
A Randomized, Phase 2 Study of Paclitaxel (p) and Carboplatin (c) +/- Conatumumab (con) for First-line Treatment of Non-small Cell Lung Cancer (nsclc)
2010 · Luis Paz‐Ares, Beatrix Bálint, et al. · University of Groningen research database (University of Groningen / Centre for Information Technology) · 2
OA23.02 Efficacy and Safety of Necitumumab Continuation Monotherapy in Patients with EGFR-Expressing Tumors in SQUIRE, a Phase 3 Study
2017 · Tudor Ciuleanu, Mark Socinski, et al. · Journal of Thoracic Oncology · 1
PDF
Works count: 37
Citation count: 2,046
H-index: 17
I10-index: 19
Year
Topic
Type